Synthesis and evaluation of novel dolastatin 10 derivatives for versatile conjugations

  • Bioorg Med Chem. 2018 May 1;26(8):1643-1652. doi: 10.1016/j.bmc.2018.02.011.
Shinya Yokosaka  1 Akiko Izawa  1 Chizuka Sakai  1 Eri Sakurada  1 Yasuhiro Morita  1 Yukihiro Nishio  2
Affiliations
  • 1. Toray Industries Inc., Pharmaceutical Research Laboratories, 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan.
  • 2. Toray Industries Inc., Pharmaceutical Research Laboratories, 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan. Electronic address: [email protected].
Abstract

Dolastatin 10 (1) is a highly potent cytotoxic microtubule inhibitor (cytotoxicity IC50 < 5.0 nM) and several of its analogs have recently been used as payloads in antibody drug conjugates. Herein, we describe the design and synthesis of a series of novel dolastatin 10 analogs useful as payloads for conjugated drugs. We explored analogs containing functional groups at the thiazole moiety at the C-terminal of dolastatin 10. The functional groups included amines, alcohols, and thiols, which are representative structures used in known conjugated drugs. These novel analogs showed excellent potency in a tumor cell proliferation assay, and thus this series of dolastatin 10 analogs is suitable as versatile payloads in conjugated drugs. Insights into the structure-activity relationships of the analogs are also discussed.

Keywords
Cytotoxicity; Dolastatin 10; Tubulin inhibitor.